Guidant Tetra Stent Approval Opens Opportunity To Recoup Lost Market Share
This article was originally published in The Gray Sheet
Executive Summary
Guidant is looking to its Multi-Link Tetra fourth-generation coronary stent platform to recoup a recent loss in U.S. stent market share, following a drop-off in demand for its Tri-Star stent.